These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 11325019
1. Na+/H+ exchange inhibitor SM-20220 improves endothelial dysfunction induced by ischemia-reperfusion. Horikawa N, Kuribayashi Y, Itoh N, Nishioka M, Matsui K, Kawamura N, Ohashi N. Jpn J Pharmacol; 2001 Mar; 85(3):271-7. PubMed ID: 11325019 [Abstract] [Full Text] [Related]
2. Na+/H+ exchange inhibitor SM-20220 attenuates leukocyte adhesion induced by ischemia-reperfusion. Horikawa N, Kuribayashi Y, Matsui K, Kawamura N, Ohashi N. J Cardiovasc Pharmacol; 2001 Jun; 37(6):668-77. PubMed ID: 11392463 [Abstract] [Full Text] [Related]
3. SM-20220, a Na(+)/H(+) exchanger inhibitor: effects on ischemic brain damage through edema and neutrophil accumulation in a rat middle cerebral artery occlusion model. Suzuki Y, Matsumoto Y, Ikeda Y, Kondo K, Ohashi N, Umemura K. Brain Res; 2002 Aug 02; 945(2):242-8. PubMed ID: 12126886 [Abstract] [Full Text] [Related]
4. Relationship between the neuroprotective effect of Na+/H+ exchanger inhibitor SM-20220 and the timing of its administration in a transient middle cerebral artery occlusion model of rats. Horikawa N, Kuribayashi Y, Matsui K, Ohashi N. Biol Pharm Bull; 2001 Jul 02; 24(7):767-71. PubMed ID: 11456115 [Abstract] [Full Text] [Related]
5. The Na(+)/H(+) exchanger SM-20220 attenuates ischemic injury in in vitro and in vivo models. Horikawa N, Nishioka M, Itoh N, Kuribayashi Y, Matsui K, Ohashi N. Pharmacology; 2001 Jul 02; 63(2):76-81. PubMed ID: 11490199 [Abstract] [Full Text] [Related]
6. Delayed treatment of Na+/H+ exchange inhibitor SM-20220 reduces infarct size in both transient and permanent middle cerebral artery occlusion in rats. Kuribayashi Y, Horikawa N, Itoh N, Kitano M, Ohashi N. Int J Tissue React; 1999 Jul 02; 21(2):29-33. PubMed ID: 10568221 [Abstract] [Full Text] [Related]
7. A Na+-H+ exchange inhibitor (SM-20550) protects from microvascular deterioration and myocardial injury after reperfusion. Ito Y, Imai S, Ui G, Nakano M, Imai K, Kamiyama H, Naganuma F, Matsui K, Ohashi N, Nagai R. Eur J Pharmacol; 1999 Jun 25; 374(3):355-66. PubMed ID: 10422780 [Abstract] [Full Text] [Related]
8. Cerebroprotective properties of SM-20220, a potent Na(+)/H(+) exchange inhibitor, in transient cerebral ischemia in rats. Kuribayashi Y, Itoh N, Kitano M, Ohashi N. Eur J Pharmacol; 1999 Oct 27; 383(2):163-8. PubMed ID: 10585530 [Abstract] [Full Text] [Related]
9. SM-20550, a new Na+/H+ exchange inhibitor and its cardioprotective effect in ischemic/reperfused isolated rat hearts by preventing Ca2+-overload. Yamamoto S, Matsui K, Kitano M, Ohashi N. J Cardiovasc Pharmacol; 2000 Jun 27; 35(6):855-62. PubMed ID: 10836718 [Abstract] [Full Text] [Related]
10. SM-20220, a potent Na+/H+ exchange inhibitor, improves consciousness recovery and neurological outcome following transient cerebral ischaemia in gerbils. Kuribayashi Y, Itoh N, Horikawa N, Ohashi N. J Pharm Pharmacol; 2000 Apr 27; 52(4):441-4. PubMed ID: 10813556 [Abstract] [Full Text] [Related]
11. The effect of an Na+/H+ exchange inhibitor, SM-20550, on ischemia/reperfusion-induced endothelial dysfunction in isolated perfused rat hearts. Yamamoto S, Matsui K, Itoh N, Ohashi N. Int J Tissue React; 2001 Apr 27; 23(1):1-7. PubMed ID: 11392059 [Abstract] [Full Text] [Related]
12. Inhibition of Na(+)/H(+) exchange by SM-20220 attenuates free fatty acid efflux in rat cerebral cortex during ischemia-reperfusion injury. Pilitsis JG, Diaz FG, O'Regan MH, Phillis JW. Brain Res; 2001 Sep 21; 913(2):156-8. PubMed ID: 11549379 [Abstract] [Full Text] [Related]
13. Na+/H+ exchanger inhibitor, SM-20220, is protective against excitotoxicity in cultured cortical neurons. Matsumoto Y, Yamamoto S, Suzuki Y, Tsuboi T, Terakawa S, Ohashi N, Umemura K. Stroke; 2004 Jan 21; 35(1):185-90. PubMed ID: 14671239 [Abstract] [Full Text] [Related]
14. Combined therapy utilizing a novel Na+/H+ exchange inhibitor (SM-20220) and THAM for ischemic brain edema. Hakamata Y, Ito U, Kuroiwa T, Hanyu S, Ohashi N, Nakano I. Acta Neurochir Suppl; 2000 Jan 21; 76():165-9. PubMed ID: 11449998 [Abstract] [Full Text] [Related]
15. Cardioprotection of SM-15681, an Na+/H+ exchange inhibitor in ischemic and hypoxic isolated perfused rat hearts. Toda H, Noguchi T, Miyagishi A, Ito N, Umekawa K, Sato Y, Kitano M, Ohashi N. Int J Tissue React; 1999 Jan 21; 21(3):61-70. PubMed ID: 10645513 [Abstract] [Full Text] [Related]
16. Intra-artery infusion of recombinant human erythropoietin reduces blood-brain barrier disruption in rats following cerebral ischemia and reperfusion. Wang R, Wu X, Liang J, Qi Z, Liu X, Min L, Ji X, Luo Y, Zhao H. Int J Neurosci; 2015 Jan 21; 125(9):693-702. PubMed ID: 25226558 [Abstract] [Full Text] [Related]
17. Protective effect of SM-20550, a selective Na+ - H+ exchange inhibitor, on ischemia-reperfusion-injured hearts. Hotta Y, Nakagawa J, Ishikawa N, Wakida Y, Ando H, Takeya K, Ohashi N, Matsui K. J Cardiovasc Pharmacol; 2001 Feb 21; 37(2):143-54. PubMed ID: 11209997 [Abstract] [Full Text] [Related]
18. Cerebral microvascular endothelial cell Na/H exchange: evidence for the presence of NHE1 and NHE2 isoforms and regulation by arginine vasopressin. Lam TI, Wise PM, O'Donnell ME. Am J Physiol Cell Physiol; 2009 Aug 21; 297(2):C278-89. PubMed ID: 19458287 [Abstract] [Full Text] [Related]
19. Neurotolerability of contrast agents in rats with brain ischemia induced by transient middle cerebral artery occlusion: EEG evaluation. Frigeni V, Miragoli L, Grotti A, Lorusso V. Invest Radiol; 2001 Jan 21; 36(1):1-8. PubMed ID: 11176255 [Abstract] [Full Text] [Related]